The novel TRAIL-receptor agonist APG350 exerts superior therapeutic activity in pancreatic cancer cellsKaren Legler, Anna Trauzold|Cell Death and Disease|2018Cited by 40
Impact of AKT1 on cell invasion and radiosensitivity in a triple negative breast cancer cell line developing brain metastasisJoanna Kempska, Karen Legler|Frontiers in Oncology|2023Cited by 10